Cosmetic / healing
Prepared by the ezGLP team. Sources last checked .
Also known as Copper peptide
Routes represented in the knowledgebase: Subcutaneous (SubQ).
GHK-Cu is listed in the ezGLP knowledgebase under Cosmetic / healing. Evidence and regulatory status can vary by formulation, route, and jurisdiction.
No validated PubMed or DOI link is currently curated for this entry.
Serious or important: potential immunogenicity, aggregation, impurity, or product-quality risks.
A dependable route-specific human interaction and side-effect profile is not established; this is not evidence of no risk.
Safety evidence sourceThese are general, pairwise evidence notes. Green identifies the potential-synergy category, while Lv3/Lv2/Lv1 communicates evidence strength; it does not guarantee benefit or cancel a safety warning.
The pair is proposed as complementary from separate preclinical findings involving tendon repair, angiogenic signaling, collagen, and extracellular-matrix accumulation.
Interaction evidence sourceGHK-Cu wound studyFDA peptide safety overviewThe pair is proposed as complementary from separate evidence involving thymosin-beta-4-related cell migration and GHK-Cu-associated matrix accumulation.
Interaction evidence sourceGHK-Cu wound studyFDA TB-500 assessmentThe pair is proposed as complementary from separate preclinical findings involving extracellular-matrix deposition and reduced inflammatory signaling.
Interaction evidence sourceKPV preclinical studyFDA KPV assessmentSummarised from published literature for reference only, with citations to the source. Evidence is graded as reported and is not a recommendation to combine, dose, or use any compound.
For personal tracking and education only. Not medical advice, diagnosis, or treatment, and not a medical device. Peptides may be prescription-only or unapproved where you live — consult a licensed healthcare professional.
